What does Baxter R And D Europe do?
Baxter R and D Europe focuses on advancing healthcare by developing innovative medical products and technologies. The company specializes in research and development in areas such as pharmaceuticals, medical devices, and biotechnology. Its mission is to improve patient outcomes through scientific innovation and collaboration.
- Signals
-
ProfitableProfitable € 2.52M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 30.51MStrong equity provides a buffer against setbacks.
Low riskLow risk 57.9%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.23A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 4.08MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 4.94MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 58.83MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 11.3%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
58.83M
|
€
56.16M
|
€
52.65M
|
€
47.21M
|
|
|
€
4.94M
|
€
4.20M
|
€
3.91M
|
€
3.91M
|
|
|
€
2.52M
|
€
11.25M
|
€
5.95M
|
€
1.99M
|
|
|
€
30.51M
|
€
28.00M
|
€
28.21M
|
€
22.26M
|
|
|
57.88%
|
58.75%
|
60.78%
|
57.78%
|
|
|
€
17.34M
|
€
14.93M
|
€
17.38M
|
€
15.78M
|
|
|
€
11.09M
|
€
7.67M
|
€
3.04M
|
€
10.03M
|
|
|
176.70
|
185.00
|
188.70
|
190.70
|
Publications 88
All publications- Demissions, Nominations 08/07/2024
- Demissions, Nominations 28/07/2023
- Demissions, Nominations 07/04/2022
- Demissions, Nominations 22/12/2021
- Demissions, Nominations 21/09/2021
Frequently asked questions
Answers to the most common questions about Baxter R And D Europe, based on official government data and the filed annual accounts.
What is the VAT number of Baxter R And D Europe?
The VAT number of Baxter R And D Europe is BE0419.859.253.
How many employees work at Baxter R And D Europe?
In 2025, Baxter R And D Europe employed 176.70 full-time equivalents (FTE).
When was Baxter R And D Europe established?
Baxter R And D Europe was founded in 15-08-1979.
What is the official address of Baxter R And D Europe?
The official address of Baxter R And D Europe is Boulevard René Branquart(L) 80 Lessines 7860.
What is the legal form of Baxter R And D Europe?
The juridical form of Baxter R And D Europe is Private limited company (BV/SRL).
What is the annual revenue of Baxter R And D Europe?
The revenue of Baxter R And D Europe for the 2025 financial year was €58,833,641.
What does Baxter R And D Europe do?
Baxter R and D Europe focuses on advancing healthcare by developing innovative medical products and technologies. The company specializes in research and development in areas such as pharmaceuticals, medical devices, and biotechnology. Its mission is to improve patient outcomes through scientific innovation and collaboration.
Is Baxter R And D Europe a reliable company?
Baxter R And D Europe is a registered Rechtspersoon with company number 0419.859.253 and can be verified through the official CBE database.
What is the credit limit of Baxter R And D Europe?
The estimated credit limit of Baxter R And D Europe is €10,000,000.
Is Baxter R And D Europe still active?
Baxter R And D Europe currently has the status "Normal situation" and is active.